ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations (NASDAQ: LUNA) announced today that it has submitted its 510(k) application to the U.S. Food and Drug Administration for the EDAC™ (Emboli Detection and Classification) QUANTIFIER. This innovative medical device uses quantitative ultrasound technology to non-invasively count and measure gaseous emboli in the extracorporeal blood circuits. FDA clearance would enable Luna Innovations to market and sell the EDAC QUANTIFIER for clinical use in the United States.
